IP Library Granted Patent US 7,541,186
Granted Patent B2
US 7,541,186 · App. 11/361,051 · Granted Jun 2, 2009

Method of generating human retinal progenitors from embryonic stem cells

Assignee: University of Washington
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,541,186
App. No.
11/361,051
Granted
Jun 2, 2009
Kind
B2
Abstract

Methods are provided for the in vitro differentiation of human retinal progenitor cells from embryonic stem cells.

Claims (11)

1. A method for in vitro differentiation of human retinal progenitor cells from human embryonic stem cells, the method comprising:

culturing said human embryonic stem cells to embryoid bodies in a conditioning medium comprising at least 1 ng/ml of insulin-like growth factor 1 (IGF-1), at least 1 ng/ml Dkk-1 and at least 1 ng/ml Noggin for 1 to 7 days in the absence of basic fibroblast growth factor (FGF2) activity; then

culturing the resulting embryoid bodies in retinal differentiation medium comprising at least 1 ng/ml of insulin-like growth factor 1 (IGF-1), at least 1 ng/ml Dkk-1, at least 1 ng/ml Noggin and at least 5 ng/ml FGF-2 for at least one week,

thereby yielding human retinal progenitor cells.

2. The method according to claim 1 , wherein said embryoid bodies are plated to adhere to a semi-solid substrate prior to culturing in retinal differentiation medium.

3. The method according to claim 2 , wherein said semi-solid substrate comprises matrigel extracellular matrix protein.

4. The method according to claim 1 , the method further comprises quantitating retinal progenitor cells in said culture.

5. The method according to claim 4 , wherein said quantitating comprises determining the expression of eye field transcription factors by cells yielded by said culturing in said retinal differentiation medium.

6. The method according to claim 5 , wherein said determining is performed by quantitative PCR.

7. The method according to claim 5 , wherein said determining is performed by antibody binding.

8. The method according to claim 1 , wherein following said culturing step, the cells are further selected to enrich for retinal progenitor cells.

Assignments (2)
CONFIRMATORY LICENSE Recorded Aug 2, 2010
From: UNIVERSITY OF WASHINGTON
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024772/0309 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2006
From: REH, THOMAS; LAMBA, DEEPAK
To: UNIVERSITY OF WASHINGTON
Reel/Frame 017715/0250 →
Continuity (1)
Related Publication 20070196919A1 · Aug 23, 2007